1-5 of 5
Jeanette Doorduijn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL

Clinical Trials & Observations
Christian H. Geisler, Mars B. van t’ Veer, Jesper Jurlander, Jan Walewski, Geir Tjønnfjord, Maija Itälä Remes, Eva Kimby, Tomas Kozak, Aaron Polliack, Ka Lung Wu, Shulamiet Wittebol, Martine C. J. Abrahamse-Testroote, Jeanette Doorduijn, Wendimagegn Ghidey Alemayehu, Marinus H. J. van Oers
Journal: Blood
Blood (2014) 123 (21): 3255–3262.
https://doi.org/10.1182/blood-2014-01-547737
Published: 2014
Includes: Supplemental data
Journal Articles

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

Francesco d'Amore, MD, DMSci, Maria Gomes da Silva, Sirpa Leppa, Thomas Relander, Antonio Pezzutto, Grete F. Lauritzsen, Eckhart Weidmann, Michel Van Gelder, Mats Merup, Hans Hagberg, Unn-Merete Fagerli, Peter de Nully Brown, Per Boye Hansen, Jose Mario Mariz, Milada Jankovska, Jan Walewski, MD, PhD, Jeanette Doorduijn, Achiel Van Hoof, Ilse Christiansen, Sirkku Jyrkkiö, J.C. Kluin-Nelemans, Marinus van Marwijk Kooy, Rob Fijnheer, Wendy Stevens, Josee Zijlstra, L. Böhmer, P.J. Lugtenburg, Matthias Grube, Vit Prochazka, David Salek, Richard Greil, MD, Lorenz Trümper, Gerald Wulf, Bettina Altmann, Marita Ziepert, Markus Loeffler, Esa Jantunen, Georg Hopfinger, Eric Van den Neste, MD, Helle Toldbod
Journal: Blood
Blood (2011) 118 (21): 4110.
https://doi.org/10.1182/blood.V118.21.4110.4110
Published: 2011
Journal Articles

High Prognostic Impact of Mixed Chimerism of Blood and Marrow In the First Year After Allogeneic Hematopoietic Stem Cell Transplantation: The Need to Rapidly Establish Complete Donor Chimerism.

Ellen Meijer, MD, PhD, Lucia Duinhouwer, Eric Braakman, PhD, Joke Boonstra, PhD, Inge de Greef, MD, PhD, Jeanette Doorduijn, MD, PhD, Mojca Lavrencic, MD, PhD, Bob Lowenberg, MD, PhD, Jan Cornelissen, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3464.
https://doi.org/10.1182/blood.V116.21.3464.3464
Published: 2010
Journal Articles

Sufficient and Timely Autologous Stem Cell Harvest After Chemoimmunotherapy with Alemtuzumab In Combination with Bi-Weekly CHOP as First Line Treatment In Systemic Peripheral T-Cell Lymphomas (PTCL): a Feasibility Analysis From the First Randomized Trial In Systemic PTCL (ACT trial)

Francesco d'Amore, Maria Gomes da Silva, Sirpa Leppa, Antonio Pezzutto, Thomas Relander, Grete Fossum Lauritzsen, Eckhart Weidmann, Michel Van Gelder, Jeanette Doorduijn, J.C. Kluin-Nelemans, Marinus van Marwijk Kooy, Rob Fijnheer, Okke de Weerdt, Peter de Nully Brown, Per Boye Hansen, Mats Merup, Matthias Grube, Jose Mario Mariz, Jan Walewski, Lorenz Truemper, Gerald Wulf, Esa Jantunen, Georg Hopfinger, it Prochazka, V
Journal: Blood
Blood (2010) 116 (21): 2395.
https://doi.org/10.1182/blood.V116.21.2395.2395
Published: 2010
Journal Articles

The Peripheral Cannabinoid Receptor CB2 and CD40 Are Novel Biological Markers That Predict Outcome in Diffuse Large B-Cell Lymphoma of Elderly Patients.

Nazik Rayman, M.D, King H. Lam, M.D, PhD, Dries A.H Mulder, M.D, PhD, Ronnie B. van der Holt, PhD, Jeanette Doorduijn, M.D, PhD, Bob Lowenberg, M.D, PhD, Pieter Sonneveld, M.D, PhD, Ruud H.R Delwel, PhD
Journal: Blood
Blood (2004) 104 (11): 3256.
https://doi.org/10.1182/blood.V104.11.3256.3256
Published: 2004